A little help keeping your community in the loop. Good stories, good company.

Explore News.ggDiscord news bot World news for Discord Gaming news and patch notes RSS feeds for Discord Stock market alerts

Blog & GuidesNews.gg Blog Crypto News & Alerts Stock Market News Bots Gaming News Bots Setup Crypto Alerts Stocks Video Guide

ProductFeatures Dashboard Pricing Support

ResourcesBlog Help & Support Discord Server Twitter / X Changelog Developer API

CompanyCommunities Careers Log In Contact

LegalPrivacy Policy Terms of Service Cookie Policy

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound | News.gg

Thursday, November 12, 2026Coverage from every side, on News.ggInternational Edition

News.gg

Home Latest Off the Radar

Subscribe Login

Published 2 days ago · CNBC · Updated 2 days ago

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

Side-by-Side Framing

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

Summary from the original article

CNBCFactualityFactuality is a Premium featureHow reliably the outlets covering this story report facts, based on their track record of accuracy and corrections.

Lean Left

Lean LeftBased on the outlet's overall lean; article framing check pending

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

By Elsa Ohlen · Nov 10, 2026, 7:52 AM UTC

Read full article at CNBC

Side-by-Side Framing

Premium

AI key points, how left, center and right framed this story, tone by side and loaded language are part of News.gg Premium.

Upgrade this server

1 Article

CNBCFactualityLean Left
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
2 days ago · cnbc.com · You are reading this one

Coverage Details

Total News Sources: 1
Leaning Left: 1
Leaning Right: 0
Center: 0
Last Updated: 2 days ago
Bias Distribution: 100% Left

Bias Distribution

• 100% of the sources are Left

L 100%

CNBCLean Left · cnbc.com

Factuality

To view factuality data please Upgrade to Premium

Bias ratings are News.gg assessments of each article's wording compared with other outlets covering the same story.